Global Health: Will 2026 See Testing Equity?

The COVID-19 pandemic exposed deep vulnerabilities in global health infrastructure, particularly in testing capacity. Despite significant advancements in diagnostic technology, the world remains ill-equipped to mount a rapid, equitable, and widespread testing response to emerging pathogens, leaving populations susceptible to unchecked disease spread. This raises a critical question: have we truly learned from the past, or are we destined to repeat the same mistakes in the face of the next global health crisis?

Persistent Inequities in Diagnostic Access and Infrastructure

The disparity in diagnostic testing capacity between high-income and low-income nations remains a glaring fault line in global health. During the COVID-19 pandemic, countries like the United States and Germany rapidly deployed millions of tests, while many nations in sub-Saharan Africa struggled to conduct even a few thousand daily. This wasn’t merely a logistical challenge. It was a fundamental failure of infrastructure and equitable access to resources. According to a 2024 report by the World Health Organization (WHO), only 15% of low-income countries have achieved sustained diagnostic testing rates comparable to high-income nations, even three years after the initial pandemic peak. This figure highlights a persistent, structural problem. We are not just talking about a lack of machines, but a lack of trained personnel, stable supply chains for reagents, and the strong laboratory networks necessary to process and interpret results effectively. Without these foundational elements, any new pathogen will disproportionately impact already vulnerable populations, creating a self-reinforcing cycle of health and economic devastation. The argument that these disparities are simply a matter of economic development misses the point. They are a consequence of inadequate global investment and coordinated effort.

Fragile Supply Chains and Manufacturing Bottlenecks

One of the most significant lessons from the recent pandemic was the fragility of global supply chains for essential medical components. The scramble for personal protective equipment (PPE), ventilators, and critically, diagnostic reagents and swabs, exposed a dangerous over-reliance on a few manufacturing hubs. When demand surged, prices skyrocketed, and access became a bidding war, leaving many nations on the sidelines. The current state is not much better. A 2025 analysis by the Coalition for Epidemic Preparedness Innovations (CEPI) found that the global manufacturing capacity for key diagnostic components remains highly concentrated, with over 70% of certain specialized reagents produced by just three companies, all located in high-income countries. This centralization creates an inherent vulnerability. A disruption, whether from a natural disaster, geopolitical event, or another pandemic-level surge in demand, could once again cripple diagnostic efforts worldwide. Building regional manufacturing capabilities, particularly in areas historically underserved, needs to be a priority. This isn’t about protectionism. It’s about resilience and ensuring that critical supplies are available closer to where they are needed, reducing transit times and dependency on complex global logistics.

The Promise and Peril of Decentralized Testing Technologies

The development of rapid antigen tests and other point-of-care diagnostics during the pandemic offered a glimpse into a more accessible future for testing. These technologies can bypass the need for centralized laboratories, bringing testing closer to communities and individuals. However, their deployment was inconsistent and often hindered by issues of cost, reliability, and regulatory hurdles. My assessment, based on years observing public health responses, is that while these technologies hold immense promise, their integration into a strong pandemic preparedness strategy requires careful planning. We need to move beyond simply developing these tools. We need to invest in their widespread adoption, ensuring they are affordable, user-friendly, and accompanied by clear guidelines for their use and interpretation. The goal should be for at least 30% of all diagnostic tests to be performable outside central laboratories by 2030, drastically improving response times in the early stages of an outbreak. This means investing in training community health workers, establishing clear protocols for self-testing, and developing digital infrastructure for reporting results. Without this, even the most innovative diagnostic tools will remain underutilized.

Funding Gaps and the Cycle of Neglect

The most persistent challenge in pandemic preparedness, and by extension, global testing capacity, is consistent funding. The cycle is predictable: a crisis hits, there’s a surge of investment and political will, then as the immediate threat recedes, funding dries up, and preparedness efforts languish. This short-sighted approach is fiscally irresponsible and morally indefensible. The World Bank estimated in 2023 that closing critical pandemic preparedness gaps globally would require an additional $10.5 billion annually. While this sounds like a substantial sum, it pales in comparison to the trillions lost in economic output during the last pandemic. Many nations, particularly in the Global South, simply do not have the domestic resources to build and maintain complete testing infrastructures without sustained international support. Plus, even in wealthier nations, health budgets often prioritize immediate clinical care over long-term public health investments. Governments must commit to allocating a minimum percentage of their annual health budget, say 0.1%, specifically to pandemic preparedness, with a clear mandate for maintaining and expanding diagnostic capabilities. Anything less is a gamble with global health and economic stability. This is not optional. It is fundamental.

Building Regional Resilience and Local Expertise

A centralized approach to global health security simply does not work. The varying epidemiological field, logistical challenges, and cultural contexts across different regions demand localized solutions. Building regional diagnostic hubs, such as those envisioned by the African Centers for Disease Control and Prevention (Africa CDC), is an important step towards fostering self-sufficiency and rapid response capabilities. These hubs can serve as training centers, reference laboratories, and coordination points for national testing strategies. They reduce reliance on external aid during emergencies and build sustainable local expertise. For example, the establishment of the West African Centre for Disease Control, with support from various international partners, has already shown how regional collaboration can strengthen surveillance and diagnostic networks. This model, where resources are pooled, knowledge is shared, and local leadership is empowered, represents a more equitable and effective path forward. It acknowledges that preparedness is not just about technology, but about people, partnerships, and resilient regional systems. The persistent gaps in global testing capacity are not merely technical hurdles. They are systemic failures rooted in inequitable resource distribution, fragmented supply chains, and insufficient political will. Addressing these challenges requires sustained investment, coordinated international action, and a fundamental shift towards building resilient, decentralized, and regionally focused diagnostic capabilities to safeguard against future health crises.